Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Brandenburg, A; Heine, A; Brossart, P.
Next-generation cancer vaccines and emerging immunotherapy combinations.
Trends Cancer. 2024; 10(8): 749-769.
Doi: 10.1016/j.trecan.2024.06.003
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Heine Annkristin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Therapeutic cancer vaccines have been a subject of research for several decades as potential new weapons to tackle malignancies. Their goal is to induce a long-lasting and efficient antitumour-directed immune response, capable of mediating tumour regression, preventing tumour progression, and eradicating minimal residual disease, while avoiding major adverse effects. Development of new vaccine technologies and antigen prediction methods has led to significant improvements in cancer vaccine efficacy. However, for their successful clinical application, certain obstacles still need to be overcome, especially tumour-mediated immunosuppression and escape mechanisms. In this review, we introduce therapeutic cancer vaccines and subsequently discuss combination approaches of next-generation cancer vaccines and existing immunotherapies, particularly immune checkpoint inhibitors (ICIs) and adoptive cell transfer/cell-based immunotherapies.
- Find related publications in this database (using NLM MeSH Indexing)
- Humans - administration & dosage
- Cancer Vaccines - therapeutic use, immunology, administration & dosage
- Neoplasms - therapy, immunology
- Immune Checkpoint Inhibitors - therapeutic use, pharmacology
- Immunotherapy - methods, trends
- Animals - administration & dosage
- Antigens, Neoplasm - immunology
- Immunotherapy, Adoptive - methods, adverse effects
- Combined Modality Therapy - methods
- Adoptive Transfer - methods